BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12658028)

  • 1. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements.
    Hashimoto J; Chonan K; Aoki Y; Ugajin T; Yamaguchi J; Nishimura T; Kikuya M; Michimata M; Matsubara M; Araki T; Hozawa A; Ohkubo T; Imai Y
    J Hypertens; 2003 Apr; 21(4):805-11. PubMed ID: 12658028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension.
    Head GA
    J Hypertens; 2003 Apr; 21(4):701-3. PubMed ID: 12658014
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.
    White WB; Mansoor GA; Pickering TG; Vidt DG; Hutchinson HG; Johnson RB; Noveck R
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):806-14. PubMed ID: 10480474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy and safety of guanabenz versus clonidine.
    Leary WP; Asmal AC; Williams PC
    S Afr Med J; 1979 Jan; 55(3):83-5. PubMed ID: 371036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of sustained blood pressure-lowering effect of azelnidipine guided by self-measured morning and evening home blood pressure: subgroup analysis of the At-HOME study.
    Kario K; Uehara Y; Shirayama M; Takahashi M; Shiosakai K; Hiramatsu K; Komiya M; Shimada K
    Drugs R D; 2013 Mar; 13(1):75-85. PubMed ID: 23519655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.
    Mori H; Yamamoto H; Ukai H; Yuasa S; Nakajima K; Mikawa T; Niizuma M; Hirao K; Umemura S;
    Hypertens Res; 2013 Mar; 36(3):202-7. PubMed ID: 23013888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Masked Hypertension in Subjects Treated with Antihypertensive Drugs as Assessed by Morning versus Evening Home Blood Pressure Measurements: the J-HOME study.
    Obara T; Ohkubo T; Asayama K; Kikuya M; Metoki H; Inoue R; Komai R; Murai K; Hashimoto J; Totsune K; Imai Y;
    Clin Exp Hypertens; 2008 Apr; 30(3):277-87. PubMed ID: 18425707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Centrally-acting antihypertensive drugs].
    Takishita S; Yamazato M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():591-5. PubMed ID: 15171442
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of imidapril in dipper and nondipper hypertensive patients: comparison between morning and evening administration.
    Kohno I; Ijiri H; Takusagawa M; Yin DF; Sano S; Ishihara T; Sawanobori T; Komori S; Tamura K
    Chronobiol Int; 2000 Mar; 17(2):209-19. PubMed ID: 10757465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of home blood pressure measured in morning and evening: evaluation in normotensives and hypertensives in Japanese urban population.
    Kawabe H; Saito I; Saruta T
    Hypertens Res; 2005 Jun; 28(6):491-8. PubMed ID: 16231754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
    Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure-lowering effect and duration of action of bedtime administration of doxazosin determined by home blood pressure measurement.
    Gonokami K; Obara T; Kobayashi M; Katada S; Hara A; Metoki H; Asayama K; Kikuya M; Ohkubo T; Imai Y
    Clin Exp Hypertens; 2010; 32(5):311-7. PubMed ID: 20662733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent effects of imidapril administration in patients with morning hypertension measured as home blood pressure.
    Shibasaki T; Obara T; Ohkubo T; Hara A; Metoki H; Inoue R; Asayama K; Kikuya M; Hashimoto J; Totsune K; Imai Y
    Clin Exp Hypertens; 2008 Apr; 30(3):243-54. PubMed ID: 18425704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of guanabenz and clonidine in hypertensive patients.
    Kluyskens Y; Snoeck J
    Curr Med Res Opin; 1980; 6(9):638-43. PubMed ID: 6996935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the difference between morning and evening home blood pressure: the Finn-Home study.
    Johansson JK; Niiranen TJ; Puukka PJ; Jula AM
    Blood Press; 2011 Feb; 20(1):27-36. PubMed ID: 20849356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of home blood pressure measuring conditions in the evening on the morning-evening home blood pressure difference in treated hypertensive patients: the J-HOME study.
    Ito K; Obara T; Ohkubo T; Gonokami K; Shinki T; Shibamiya T; Nakashita M; Kobayashi M; Funahashi J; Hara A; Metoki H; Asayama K; Inoue R; Kikuya M; Mano N; Imai Y;
    Blood Press Monit; 2009 Aug; 14(4):160-5. PubMed ID: 19550298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.